Immunic Inc. (IMUX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Immunic Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.98
+4.86% today
Market cap
$104M
Overall quality
—
Kronos AI 30-day
+72.4%
8 of 8 simulated paths end higher
Immunic Inc. (IMUX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $104M. It trades at $7.98, up 4.86% today. 10 analysts' average target of $36.56 implies +358.1% from today's price. Kronos AI's 30-day forecast is +72.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $36.56 |
| Low – high | $22.00 – $70.00 |
| Analysts | 10 |
| Upside to average | +358.1% |
Kronos AI 30-day forecast
| Expected close | $13.12 (+72.4%) |
| Likely range | +58.3% … +84.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.